BRIEF published on 01/12/2026 at 08:05, 2 months 7 days ago Molten Ventures Announces Share Buyback Details Ordinary Shares Share Buyback Financial Conduct Authority Molten Ventures Goodbody Stockbrokers
PRESS RELEASE published on 01/12/2026 at 08:00, 2 months 7 days ago Transaction in Own Shares Molten Ventures Plc (GROW) announces transaction in own shares. Goodbody Stockbrokers UC purchased 50,000 Ordinary Shares on 09/01/2026 at prices ranging from 511.50p to 519.00p Shares Molten Ventures Plc GROW Transaction Goodbody Stockbrokers UC
BRIEF published on 01/09/2026 at 08:05, 2 months 10 days ago Molten Ventures Executes Share Buyback Share Buyback Molten Ventures Financial Regulations Capital Management LSE: GROW
PRESS RELEASE published on 01/09/2026 at 08:00, 2 months 10 days ago Transaction in Own Shares Molten Ventures plc (LSE: GROW) announces purchase of 50,000 Ordinary Shares as part of share repurchase program. Prices ranged from 512.50p to 519.00p Share Repurchase Ordinary Shares Molten Ventures Plc Stock Purchase GROW
BRIEF published on 01/08/2026 at 08:05, 2 months 11 days ago Molten Ventures Executes Share Buyback Programme Share Buyback Investment Stock Market Molten Ventures Financial Transaction
PRESS RELEASE published on 01/08/2026 at 08:00, 2 months 11 days ago Transaction in Own Shares Molten Ventures plc (LSE: GROW) announces purchase of 50,000 own shares on 7 January 2026 at prices ranging from 507.50p to 516.50p. Total voting rights now at 175,418,854 Voting Rights Molten Ventures Plc Own Shares Share Purchase LSE: GROW
BRIEF published on 01/07/2026 at 08:05, 2 months 12 days ago Molten Ventures Executes Share Repurchase Program Share Repurchase Ordinary Shares Market Abuse Regulation Financial Conduct Authority Molten Ventures
PRESS RELEASE published on 01/07/2026 at 08:00, 2 months 12 days ago Transaction in Own Shares Molten Ventures Plc (LSE: GROW) reports transaction in own shares, purchasing 50,000 Ordinary Shares at 515.0325p average price per share on 6 Jan 2026 Share Repurchase Molten Ventures Plc Own Shares GROW Transaction
BRIEF published on 01/06/2026 at 08:05, 2 months 13 days ago Molten Ventures Plc Announces Share Repurchase Ordinary Shares Share Buyback Molten Ventures Market Regulation Goodbody Stockbrokers
PRESS RELEASE published on 01/06/2026 at 08:00, 2 months 13 days ago Transaction in Own Shares Molten Ventures plc (LSE: GROW) announces the purchase of 41,484 Ordinary Shares at prices ranging from 509.50p to 519.50p each. Details disclosed for transparency Share Repurchase Ordinary Shares Molten Ventures Plc GROW Goodbody Stockbrokers UC
Published on 03/19/2026 at 07:30, 35 minutes ago Tocvan Drone Magnetic Data Strengthens Gold-Silver Targets Across Gran Pilar; Identifies Broad Zones for Expansion Potential
Published on 03/19/2026 at 06:35, 1 hour 30 minutes ago Golden Lake Announces Securityholder Approval of Arrangement with McEwen Inc.
Published on 03/19/2026 at 01:05, 7 hours ago Prospect Ridge Announces Closing of Flow-Through Share Private Placement
Published on 03/18/2026 at 23:45, 8 hours 20 minutes ago Orogen Royalties Announces Private Placement Update
Published on 03/18/2026 at 21:00, 11 hours 5 minutes ago PLDT's Smart Selects Amdocs to Transform Retail Operations with AI-Powered Store Genie
Published on 03/19/2026 at 07:50, 15 minutes ago AFYREN obtains ISO 9001 certification, a globally acknowledged standard of rigor and performance, for its AFYREN NEOXY plant
Published on 03/19/2026 at 07:35, 30 minutes ago Lenzing advances its transformation: Higher EBITDA, stronger free cash flow and more than EUR 200 million in cost savings
Published on 03/19/2026 at 07:30, 35 minutes ago Additional Phase 2 Data of AL-S Pharma’s Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS
Published on 03/19/2026 at 07:30, 35 minutes ago The Nordex Group receives orders totaling 54 MW from Prowind in Germany
Published on 03/19/2026 at 07:30, 35 minutes ago Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation
Published on 03/19/2026 at 07:00, 1 hour 5 minutes ago bioMérieux Receives IVDR CE‑Marking for Two BIOFIRE® SPOTFIRE® Panels to Strengthen Near‑Patient Respiratory and Sore Throat Diagnostics Across Europe
Published on 03/19/2026 at 07:00, 1 hour 5 minutes ago 2025 Annual results and new strategic signature
Published on 03/18/2026 at 19:41, 12 hours 23 minutes ago Covivio - Conditions of availability of the 2025 Universal Registration Document
Published on 03/18/2026 at 18:00, 14 hours 5 minutes ago Deezer achieves profitability in FY25 as strategy delivers tangible results
Published on 03/18/2026 at 17:45, 14 hours 20 minutes ago Infotel : 2025 full-year results. Launch of a new Infotel 2030 strategic plan. Revenue target of €500 million by 2030.
